- Home
- MGIC vs LYEL Comparison
MGIC vs LYEL Comparison
Compare MGIC & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- LYEL
- Stock Information
- Founded
- MGIC 1983
- LYEL 2018
- Country
- MGIC Israel
- LYEL United States
- Employees
- MGIC N/A
- LYEL N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- LYEL Health Care
- Exchange
- MGIC Nasdaq
- LYEL Nasdaq
- Market Cap
- MGIC N/A
- LYEL 263.9M
- IPO Year
- MGIC 1991
- LYEL 2021
- Fundamental
- Price
- MGIC $11.89
- LYEL $0.65
- Analyst Decision
- MGIC Buy
- LYEL Sell
- Analyst Count
- MGIC 1
- LYEL 2
- Target Price
- MGIC $15.00
- LYEL $1.00
- AVG Volume (30 Days)
- MGIC 42.2K
- LYEL 1.3M
- Earning Date
- MGIC 11-18-2024
- LYEL 02-26-2025
- Dividend Yield
- MGIC 1.71%
- LYEL N/A
- EPS Growth
- MGIC N/A
- LYEL N/A
- EPS
- MGIC 0.70
- LYEL N/A
- Revenue
- MGIC $535,482,999.00
- LYEL $63,000.00
- Revenue This Year
- MGIC $4.29
- LYEL N/A
- Revenue Next Year
- MGIC $3.39
- LYEL N/A
- P/E Ratio
- MGIC $17.20
- LYEL N/A
- Revenue Growth
- MGIC N/A
- LYEL N/A
- 52 Week Low
- MGIC $9.38
- LYEL $0.58
- 52 Week High
- MGIC $13.40
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- MGIC 49.67
- LYEL 34.74
- Support Level
- MGIC $11.51
- LYEL $0.60
- Resistance Level
- MGIC $12.24
- LYEL $0.71
- Average True Range (ATR)
- MGIC 0.30
- LYEL 0.06
- MACD
- MGIC -0.07
- LYEL 0.01
- Stochastic Oscillator
- MGIC 33.33
- LYEL 23.51
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.